Evidence map›Paper›PMID 28790306›Full record

ArticleScientific reports2017

Quantitative diagnostic imaging of cancer tissues by using phosphor-integrated dots with ultra-high brightness.

Kohsuke Gonda, Mika Watanabe, Hiroshi Tada, Minoru Miyashita, Yayoi Takahashi-Aoyama, Takashi Kamei, Takanori Ishida, Shin Usami, Hisashi Hirakawa, Yoichiro Kakugawa and 12 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 49 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. New Technologies to Image Tumors.Cancer treatment and research · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. pH-dependent and cathepsin B activable CaCOInternational journal of nanomedicine · 2019
    Article
  17. Article
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 1 country.

Kohsuke GondaDepartment of Medical Physics, Graduate School of Medicine, Tohoku University, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan. gonda@med.tohoku.ac.jp.
Mika WatanabeDepartment of Pathology, Tohoku University Hospital, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Hiroshi TadaDepartment of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Minoru MiyashitaDepartment of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Yayoi Takahashi-AoyamaDepartment of Pathology, Tohoku University Hospital, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Takashi KameiDepartment of Gastroenterological Surgery, Graduate School of Medicine, Tohoku University, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Takanori IshidaDepartment of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Shin UsamiDepartment of Breast Surgery, Iwate Prefectural Central Hospital, Ueda, Morioka, 020-0066, Japan.
Hisashi HirakawaDepartment of Breast Surgery, Tohoku Kosai Hospital, Kokubuncho, Aoba-ku, Sendai, 980-0803, Japan.
Yoichiro KakugawaDepartment of Breast Surgery, Miyagi Cancer Center Hospital, Medeshima, Natori, 981-1293, Japan.
Yohei HamanakaDepartment of Breast and Endocrine Surgical Oncology, Graduate School of Medicine, Tohoku University, Seiryo-machi, Aoba-ku, Sendai, 980-8574, Japan.
Ryuichi YoshidaDepartment of Breast Surgery, Osaki Citizen Hospital, Furukawa, Osaki, 989-6174, Japan.
Akihiko FurutaDepartment of breast surgery, Japanese Red Cross Ishinomaki Hospital, Ishinomaki, Miyagi, 986-8522, Japan.
Hisatake OkadaBio Health Care, Business Development Division, Business Development Headquarters, Konica Minolta, Inc., No. 1, Sakura-machi, Hino-shi, Tokyo, 191-8511, Japan.
Hideki GodaBio Health Care, Business Development Division, Business Development Headquarters, Konica Minolta, Inc., No. 1, Sakura-machi, Hino-shi, Tokyo, 191-8511, Japan.
Hiroshi NegishiBio Health Care, Business Development Division, Business Development Headquarters, Konica Minolta, Inc., No. 1, Sakura-machi, Hino-shi, Tokyo, 191-8511, Japan.ORCID 0000-0002-9889-086X
Kensaku TakanashiBio Health Care, Business Development Division, Business Development Headquarters, Konica Minolta, Inc., No. 1, Sakura-machi, Hino-shi, Tokyo, 191-8511, Japan.
Masaru TakahashiBio Health Care, Business Development Division, Business Development Headquarters, Konica Minolta, Inc., No. 1, Sakura-machi, Hino-shi, Tokyo, 191-8511, Japan.
Yuichi OzakiData Science Center, Systems Technology Division, Business Development Headquarters, Konica Minolta, Inc., No. 1 Sakura-machi, Hino-shi, Tokyo, 191-8511, Japan.
Yuka YoshiharaBio Health Care, Business Development Division, Business Development Headquarters, Konica Minolta, Inc., No. 1, Sakura-machi, Hino-shi, Tokyo, 191-8511, Japan.
Yasushi NakanoBio Health Care, Business Development Division, Business Development Headquarters, Konica Minolta, Inc., No. 1, Sakura-machi, Hino-shi, Tokyo, 191-8511, Japan.
Noriaki OhuchiDepartment of Nano-Medical Science, Graduate School of Medicine, Tohoku University, Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.
Konica Minolta (Japan) · JPTohoku University · JPTohoku University Hospital · JPIwate Prefectural Central Hospital · JPKKR Tohoku Kosai Hospital · JPMiyagi Prefectural Hospital Organization · JPOsaki Citizen Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The quantitative sensitivity and dynamic range of conventional immunohistochemistry (IHC) with 3,3'-diaminobenzidine (IHC-DAB) used in pathological diagnosis in hospitals are poor, because enzyme activity can affect the IHC-DAB chromogenic reaction. Although fluorescent IHC can effectively increase the quantitative sensitivity of conventional IHC, tissue autofluorescence interferes with the sensitivity. Here, we created new fluorescent nanoparticles called phosphor-integrated dots (PIDs). PIDs have 100-fold greater brightness and a more than 300-fold greater dynamic range than those of commercially available fluorescent nanoparticles, quantum dots, whose fluorescence intensity is comparable to tissue autofluorescence. Additionally, a newly developed image-processing method enabled the calculation of the PID particle number in the obtained image. To quantify the sensitivity of IHC using PIDs (IHC-PIDs), the IHC-PIDs method was compared with fluorescence-activated cell sorting (FACS), a method well suited for evaluating total protein amount, and the two values exhibited strong correlation (R = 0.94). We next applied IHC-PIDs to categorize the response to molecular target-based drug therapy in breast cancer patients. The results suggested that the PID particle number estimated by IHC-PIDs of breast cancer tissues obtained from biopsy before chemotherapy can provide a score for predicting the therapeutic effect of the human epidermal growth factor receptor 2-targeted drug trastuzumab.

Indexed as

3,3'-DiaminobenzidineAntibodiesAntineoplastic Agents, ImmunologicalBiopsyBiotinBreast NeoplasmsDiagnostic ImagingErb-b2 Receptor Tyrosine KinasesFemaleFluorescenceFluorescent DyesGene ExpressionHumansImidesImmunohistochemistryMiddle Aged3,3'-DiaminobenzidineAntibodiesAntineoplastic Agents, ImmunologicalBiotinERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesFluorescent DyesImidesNeoplasm ProteinsPeryleneperylene bisimideRhodaminesStreptavidintetramethylrhodamineTrastuzumab

Identifiers

PMID28790306
PMCPMC5548777
OpenAlexW2741148391

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.